Sharon Friedlander, based in Boston, MA, US, is currently a Associate Director, Reverse Translation Development Lead. OTAU at Takeda Oncology, bringing experience from previous roles at Takeda Oncology, Deciphera Pharmaceuticals and Karyopharm Therapeutics Inc.. Sharon Friedlander holds a 2004 - 2010 Massachusetts Institute of Technology. With a robust skill set that includes Gene Expression Profiling, Gene Expression, Immunohistochemistry, Cell Culture, Fluorescence Microscopy and more, Sharon Friedlander contributes valuable insights to the industry. Sharon Friedlander has 2 emails on RocketReach.